Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Industry Expected To Reach By 2029, Starting From 2025 Levels?
The market size for pharmaceutical contract development and manufacturing organizations (CDMO) focusing on formulations has demonstrated swift growth in recent years. This market is projected to expand from $49.32 billion in 2024 to reach $54.73 billion by 2025, driven by a compound annual growth rate (CAGR) of 11.0%. Historically, this growth has been primarily due to increased pharmaceutical outsourcing, the escalating complexity of drug formulations, cost-efficiency measures undertaken by pharmaceutical companies, the surging need for generics and biosimilars, and the proliferation of small and medium-sized pharmaceutical enterprises.
The pharmaceutical contract development and manufacturing organization (CDMO) for formulations market is projected to experience substantial growth over the next few years, reaching $82.15 billion by 2029, with a compound annual growth rate (CAGR) of 10.7%. This anticipated expansion can be attributed to several factors, including a surge in biologics and advanced therapies, the increasing prevalence of personalized medicine, a heightened emphasis on continuous manufacturing, supportive regulatory frameworks for outsourcing, and the growing adoption of digitalization and automation in manufacturing. Prominent trends expected during the forecast period include the rise of continuous manufacturing, the integration of artificial intelligence and machine learning in drug development, an expansion of high-potency API (HPAPI) handling capabilities, the increasing embrace of biologics and complex injectable formulations, and a stronger focus on sustainable and green manufacturing practices.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25876&type=smp
Which Factors And Drivers Are Influencing The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market In 2025?
An anticipated boost in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market going forward is linked to the increasing drug development and manufacturing efforts. These activities encompass the expanded endeavors of pharmaceutical and biopharmaceutical firms in researching, formulating, and producing novel medications. The primary cause for the surge in drug development and manufacturing activities is the escalating worldwide need for innovative and potent treatments, compelling companies to broaden their development initiatives and accelerate production schedules. A pharmaceutical CDMO assists drug development processes through the creation and refinement of dosage forms, conducting stability tests, and upholding regulatory standards. Additionally, it oversees scale-up operations and overall production, which facilitates quicker and more economical product introductions. For example, data from June 2023 provided by the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association representing the pharmaceutical industry in Europe, indicated that the total pharmaceutical production in Europe reached $422,803 million (€390,000 million) in 2023, an increase from $393,857 million (€363,300 million) in 2022. Consequently, the expansion in drug development and manufacturing activities is a key factor propelling the growth of the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market.
What Are The Primary Types Of Segments Analyzed In The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market?
The pharmaceutical contract development and manufacturing organization (cdmo) for formulations market covered in this report is segmented –
1) By Dosage Form: Oral Solids, Oral Liquids, Injectables, Topicals, Inhalation Products, Transdermal And Patches, Other Dosage Forms
2) By Therapeutic Area: Oncology, Cardiology, Central Nervous System, Gastroenterology, Infectious Diseases, Endocrinology
3) By End-User: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Users
Subsegments:
1) By Oral Solids: Tablets, Capsules, Granules, Powders, Modified-Release Formulations
2) By Oral Liquids: Syrups, Suspensions, Solutions, Emulsions, Elixirs
3) By Injectables: Vials, Ampoules, Prefilled Syringes, Lyophilized Injections, Injectable Emulsions
4) By Topicals: Creams, Ointments, Gels, Lotions, Foams,
5) By Inhalation Products: Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizer Solutions, Nasal Sprays, Inhalation Capsules
6) By Transdermal And Patches: Matrix Patches, Reservoir Patches, Drug-In-Adhesive Patches, Microneedle Patches, Iontophoretic Patches
7) By Other Dosage Forms: Suppositories, Ophthalmic Preparations, Buccal Tablets, Sublingual Tablets, Implants
Which Ongoing Trends Are Expected To Shape The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Outlook?
Major companies operating in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market are focusing on developing advanced solutions, including biologic formulation platforms, to improve drug stability and quicken the market entry of complex biologic therapies. Biologic formulation platforms are specialized systems engineered to produce stable and efficient formulations of biologic drugs. They carefully adjust factors such as pH, excipients, and delivery methods to enhance stability, bioavailability, and safety throughout the entire product lifecycle. For instance, in June 2025, WuXi Biologics, a China-based contract research, development, and manufacturing organization, introduced WuXiHigh 2.0, an advanced high-concentration formulation platform. This cutting-edge platform enables biologic formulations to achieve protein concentrations up to 230 mg/mL, surpassing the current Food and Drug Administration-approved maximum of 200 mg/mL, while also reducing viscosity by up to 90% through unique excipient blends and high-throughput instrumentation. It addresses key difficulties in creating high-concentration biologics, such as viscosity and aggregation, and is designed to enhance injection efficiency, patient compliance, and manufacturing outcomes throughout clinical and commercial phases.
Who Are The Core Companies Influencing The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Landscape?
Major companies operating in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market are Thermo Fisher Scientific Inc., Lonza Group, Catalent Inc., WuXi Biologics, Samsung Biologics, Recipharm AB, Siegfried Holding AG, Evonik Industries AG, Almac Group, Aenova Group, Piramal Pharma Limited, Cambrex, Jubilant Pharmova Limited, CordenPharma, Altasciences, Hovione, Aurigene Pharmaceutical Services Ltd., DPT Laboratories Ltd., CARBOGEN AMCIS, Biopharma Group, LGM Pharma, Aarti Pharmalabs Limited.
Download The Full Report For Exclusive Market Findings:
What Are The Key Regional Factors Influencing The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Growth?
Asia-Pacific was the largest region in the pharmaceutical contract development and manufacturing organization (CDMO) for formulations market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cdmo) for formulations market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25876&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CDMO) For Formulations Market 2025, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Global Market Report 2025
Topical Drugs Contract Development And Manufacturing Organization Cdmo Global Market Report 2025
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model